Congressional Cannabis Caucus Co-Chair Dina Titus Calls for Equal Federal Standards for Marijuana and Intoxicating Hemp Products

Congressmember Dina Titus (D-NV)

Congressional Cannabis Caucus Co-Chair Representative Dina Titus (D-NV) says marijuana and hemp-derived products should be subject to the same basic regulatory standards when they produce similar intoxicating effects, as Congress considers legislation addressing the hemp market ahead of a December 11 federal deadline.

In a statement provided exclusively to The Marijuana Herald on Tuesday, Titus emphasized the need for consistent federal regulations, expanded research and changes to federal tax policies affecting the cannabis industry.

“As Co-Chair of the Congressional Cannabis Caucus, I have long advocated for bringing cannabis policy into the 21st century. That means advancing research, reforming outdated tax policies, and establishing clear, consistent regulations,” said Titus.

“Marijuana and hemp-derived substances should be held to the same basic standards when they produce similar intoxicating effects, ensuring consumers are protected regardless of how these products are classified. I will continue working to modernize cannabis policy to reflect science, keep pace with our changing marketplace, and provide clear rules for businesses and consumers alike.”

Her comments come as lawmakers debate whether to establish a federal regulatory framework for intoxicating hemp products before restrictions take effect on December 11.

On Monday, Representative Morgan Griffith (R-VA) told Roll Call that a Republican budget reconciliation package could provide an opportunity to advance legislation regulating hemp-derived THC products during Congress’s upcoming lame-duck session.

Griffith, alongside Representative Marc Veasey (D-TX), introduced the Hemp Enforcement, Modernization, and Protection (HEMP) Act, H.R. 7212, earlier this year. The legislation would direct the Food and Drug Administration (FDA) to develop federal regulations for cannabinoid hemp products, including limits on intoxicating substances.

Griffith has also discussed potentially combining his proposal with legislation establishing federal taxes on hemp-derived products, including the Beverage Regulatory Parity Act introduced by Representatives Beth Van Duyne (R-TX) and Greg Landsman (D-OH). Such an approach could help satisfy the budgetary requirements of the reconciliation process.

Under legislation approved in 2025, the federal definition of hemp is being narrowed to exclude numerous cannabinoid products, including finished products containing more than 0.4 milligrams of total THC per container. Congress subsequently delayed the implementation of most of those restrictions from November 12 to December 11, providing additional time for negotiations.

Titus did not explicitly endorse Griffith’s legislation or the possibility of using reconciliation to advance hemp regulations. However, her statement emphasizes applying comparable standards to marijuana and hemp products based on their intoxicating effects rather than their classifications under federal law.

Titus became a co-chair of the Congressional Cannabis Caucus in January 2025 and has supported federal marijuana reforms involving banking access, tax treatment, research and changes to federal marijuana scheduling.